Speaking in low tones in a busy Starbucks coffee shop in central Shanghai, a young man recalls his experience as a former drug salesman for GlaxoSmithKline, writes Patti Waldmeir.
“We did get training in compliance,” he says. “But then our team leader took us off individually to tell us how to offer kickbacks. We weren’t allowed to talk about that in the office.”
The young man, who declines to be named since his conduct may have been illegal, is in many ways typical of the vast salesforce of drug reps employed by domestic and foreign pharmaceutical companies in this country of 1.4bn people. He is 20-something and eager to make money.
您已閱讀20%（639字），剩餘80%（2487字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。